Untitled

Flaminio, M. Julia B.F.; Rush, Bonnie R.; Davis, Elizabeth G.; Hennessy, K J; Shuman, Wilma; Wilkerson, Melinda J.

doi:10.1023/a:1014033016308

Cited by 32 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…When the bacteria is phagocyted, the cell generates ROS and the color intensity changes. The ROS produced during phagocytosis has antimicrobial activity due to microbial DNA and protein damage [ 23 , 24 ].…”

Section: Resultsmentioning

confidence: 99%

Galactoligosaccharide and a prebiotic blend improve colonic health and immunity of adult dogs

Rentas

Pedreira²,

Perini

et al. 2020

PLoS ONE

View full text Add to dashboard Cite

This study aimed to evaluate the effects of two prebiotics in different concentrations on nutrient digestibility, fermentative products and immunological variables in adult dogs. Twentyfour adult dogs were randomly divided into six blocks according to their metabolic body weights (BW 0.75); within these groups, dogs were randomized to four treatments: control without prebiotics (CO); inclusion of 0.5% prebiotic blend Yes-Golf (B1); inclusion of 1.0% galactooligosaccharide (GOS); and inclusion of 1.0% prebiotic blend Yes-Golf (B2). The experiment lasted 30 days, with 20 days adaptation and 10 days stool and blood collection. Results were analyzed for normality and means were separated by ANOVA and adjusted by the Tukey test at the significance level of 5.0%. Prebiotic supplementation had no effect on apparent digestibility coefficients (ADC), total stool production and fecal scores (p > 0.05). Prebiotics evaluated also did not alter fecal pH, nor the concentrations of ammonia, lactic acid, short chain fatty acids (SCFA) and most fecal branched chain fatty acids (BCFA) (p > 0.05). The addition of GOS decreased the concentration of iso-valeric acid (p = 0.0423). Regarding immunological variables, concentrations of fecal IgA were not influenced by the treatments. Treatments GOS and B2 increased the total number of polymorphonuclear cells, as well as the oxidative burst in relation to treatments B1 and CO (p < 0.0001). Treatment B2 improved the rate of S. aureus phagocytosis in relation to CO (p = 0.0111), and both the GOS and B2 treatments had a better index for E. coli phagocytosis than the CO treatment (p = 0.0067). In conclusion, there was indication that both prebiotics GOS and B2 at 1.0% inclusion improved the immunity of healthy dogs.

show abstract

Section: Resultsmentioning

confidence: 99%